Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Perspective Therapeutics Inc.
CATX | US
3.60
USD-0.06
-1.64%
CATX | US
Loading StockChartView...
About Perspective Therapeutics Inc.
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
02/06/2026
Close
3.60
Open
3.64
High
3.71
Low
3.56
Perspective Therapeutics Inc. together with its subsidiaries develops manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate brain lung head and neck gynecological pelvic/abdominal and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray Inc. and changed its name to Perspective Therapeutics Inc. in February 2022. Perspective Therapeutics Inc. was founded in 1998 and is based in Richland Washington.
View LessCATX | US
Risk
62.5
Sharpe
0.30
Luna's Score
30/100
Recommendation
Sell
Luna says (CATX | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
60.0%1 month
62.5%3 months
61.2%6 months
128.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.50
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-21.91
Ent. to rev.
68.73
PEG
-
Other Fundamentals
EBITDA
-47.27M
MarketCap
242.74M
MarketCap(USD)
242.74M
Div. yield
-
Op. margin
-2.71K
Erngs. growth
-
Rev. growth
-10.50
Ret. on equity
-23.20
Short ratio
8.97
Short perc.
17.32
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.78
Range1M
0.82
Range3M
2.29
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.73
Price X volume
3.62M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -21.91 | 46.09 | Cheaper |
| Ent. to Revenue | 68.73 | 14.34 | Expensive |
| PE Ratio | - | 30.41 | - |
| Price to Book | 2.50 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 61.21 | 64.12 | Par |
| Debt to Equity | - | -145.53 | - |
| Debt to Assets | - | 0.35 | - |
| Market Cap | 242.74M | 9.70B | Emerging |
